UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 27, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organization) ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 28, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Boston, Massachusetts (Zip Code) (Address of principal executive ...

Haemonetics Corporation (NYSE:HAE) Q4 2020 Earnings Conference Call May 5, 2020 8:00 AM ET Company Participants Olga Guyette – Director-Investor Relations Chris Simon – Chief Executive Officer Bill Burke – Chief Financial Officer Conference Call Participants David Lewis – Morgan Stanley Larry Keusch – Raymond James Anthony Petrone – Jefferies Dave Turkaly – JMP Larry Solow – CJS Securities Mike Matson – Needham & Company Operator Good day, ladies and gentlemen, and welcome to the Haemonetics Fourth Quarter ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organizat ...

Haemonetics Corporation (NYSE:HAE) Q3 2020 Earnings Conference Call February 4, 2020 8:00 AM ET Company Participants Olga Guyette - Director of Investor Relations Christopher Simon - President and Chief Executive Officer William Burke - Chief Financial Officer Conference Call Participants Anthony Petrone - Jefferies & Company, Inc. Lawrence Keusch - Raymond James Financial, Inc. David Turkaly - JMP Securities LLC Mason Austen - Morgan Stanley Michael Matson - Needham & Company, LLC Operator Ladies and gentl ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ For the quarterly period ended: September 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organiza ...

Haemonetics Corporation (NYSE:HAE) Q2 2020 Earnings Conference Call November 1, 2019 8:00 AM ET Company Participants Olga Guyette - Senior Manager, IR Chris Simon - CEO Bill Burke - CFO Conference Call Participants Anthony Petrone - Jefferies David Lewis - Morgan Stanley John Hsu - Raymond James Dave Turkaly - JMP Securities Larry Solow - CJS Securities Operator Ladies and gentlemen, thank you for standing by and welcome to the Haemonetics Second Quarter 2020 Conference Call. At this time, all participants ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ For the quarterly period ended: June 29, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organization) ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 400 Wood Road, Braintree, Massachusetts 02184-9114 For the fiscal year ended March 30, 2019 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES E ...

Haemonetics Corporation (NYSE:HAE) Q4 2019 Earnings Conference Call May 7, 2019 8:00 AM ET Company Participants Olga Vlasova – Investor Relations Chris Simon – Chief Executive Officer Bill burke – Chief Financial Officer Conference Call Participants David Lewis – Morgan Stanley Anthony Petrone – Jefferies Dave Turkaly – JMP Securities Larry Keusch – Raymond James Mike Petusky – Barrington Research Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal 2019 Haemonetics Conferen ...